Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Terminated · Phase 3 · NCT03440372
Conditions: Crohn Disease
At a glance
- Research payments reported, 2025
- $292,597
- U.S. investigators named
- 17
- Sites paid
- 18
- Planned or actual enrollment
- 625
About the trial
- Sponsor
- Celgene
- Tested
- Ozanimod (drug), Placebo (other)
- Dates
- Started 2018-02-27; completion 2024-10-01
- Results posted
- Yes
This is a study to explore the effect of oral ozanimod as an induction treatment for participants with moderately to severely active Crohn's Disease.
From ClinicalTrials.gov, last updated 2025-11-04. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Celgene Corporation reported $292,597 in research payments for this study in 2025 (19 payments).
Products named: Zeposia
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Amit Bhanvadia, M.D. Gastroenterology · Anaheim, CA
- Hyun S. Kim, MD Gastroenterology · San Diego, CA
- Deborah D. Proctor, MD Gastroenterology · New Haven, CT
- Salam F. Zakko, MD Gastroenterology · Bristol, CT
- Ammar Hemaidan, MD Gastroenterology · Port Orange, FL
- Joseph D. Frasca, M.D. Gastroenterology · Chicago, IL
- Jessica R. Allegretti, M.D. Gastroenterology · Boston, MA
- Kenolisa C. Onwueme, M.D., PH.D. Gastroenterology · Baltimore, MD
- Alyssa M. Parian, MD Gastroenterology · Baltimore, MD
- Parakkal Deepak, MD Gastroenterology · Saint Louis, MO
- Nilesh I. Lodhia, MD Gastroenterology · Charlotte, NC
- Keith Sultan, MD Gastroenterology · Manhasset, NY
- Arun Swaminath, M.D. Gastroenterology · New York, NY
- Lisa A. Mueller, MD Gastroenterology · Providence, RI
- Erin M. Forster, M.D. Gastroenterology · Charleston, SC
- Dilawar Ajani, M.D. Internal Medicine · Houston, TX
- Jessica B. Johnson, MD Gastroenterology · Salt Lake City, UT
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Medical University of South Carolina $76,256
- Texas Digestive Disease Consultants Southlake $64,420
- Medical Associates Research Group, Inc $50,880
- Topography Health Inc $22,367
- Biomedical Research Alliance of New York, Llc $15,703
- Sct Research Llc $15,350
- Rush University Medical Center, IL $11,810
- University of Utah Hospital and Clinics, UT $8,976
- Johns Hopkins Office of Research Administration $6,700
- Carolinas Medical Center-Northeast, NC $4,700
- Lee Daeyeol Mms $3,640
- Washington University $2,700
- Connecticut Clinical Research Institute Llc $2,500
- Brigham and Womens Physicians Organization $2,000
- Clinical Research Manager $1,640
- Advanced Medical Research Center $1,500
- Woodholme Gastroenterology Associates $750
- Oc Gastrocare $705
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.